Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Veljko Rogošić is active.

Publication


Featured researches published by Veljko Rogošić.


Clinical Interventions in Aging | 2013

The influence of selective vitamin D receptor activator paricalcitol on cardiovascular system and cardiorenal protection

Darko Duplančić; Marijan Cesarik; Nikola Kolja Poljak; Maja Radman; Vedran Kovacic; Josipa Radić; Veljko Rogošić

The ubiquitous distribution of vitamin D receptors in the human body is responsible for the pleiotropic effects of vitamin D-receptor activation. We discuss the possible beneficial effects of a selective activator of vitamin D receptor, paricalcitol, on the cardiovascular system in chronic heart failure patients and chronic kidney patients, in light of new trials. Paricalcitol should provide additional clinical benefits over the standard treatment for chronic kidney and heart failure, especially in cases of cardiorenal syndrome.


Oxidative Medicine and Cellular Longevity | 2015

Association of Age-Related Macular Degeneration with Erythrocyte Antioxidant Enzymes Activity and Serum Total Antioxidant Status

Ivna Pleština-Borjan; Damir Katusic; Maria Medvidovic-Grubisic; Daniela Supe-Domic; Kajo Bućan; Leida Tandara; Veljko Rogošić

The aim was to estimate association of the oxidative stress with the occurrence of age-related macular degeneration (AMD). The activities of erythrocyte antioxidant enzymes: superoxide dismutase (SOD), glutathione peroxidase (GPx) and catalase (CAT) and additionally serum total antioxidant status (TAS) were used as indicators of the oxidative stress level. 57 AMD patients (32 early and 25 late AMD) and 50 healthy, age and gender matched controls were included. GPx activity (P < 0.001) and serum TAS (P = 0.015) were significantly lower in AMD patients. The difference was not significant for SOD or CAT activities. Significant interaction between GPx and SOD was detected (P = 0.003). At high levels of SOD activity (over 75th percentile), one standard deviation decrease in GPx increases the odds for AMD for six times (OR = 6.22; P < 0.001). ROC analysis revealed that combined values of GPx activity and TAS are significant determinants of AMD status. Accuracy, sensitivity, specificity, and positive and negative predictive values were 75%, 95%, 52%, 69%, and 90%, respectively. The study showed that low GPx activity and TAS are associated with AMD. SOD modulates the association of GPx and AMD. The results suggest that erythrocyte antioxidant enzymes activity and serum TAS could be promising markers for the prediction of AMD.


Acta Histochemica | 2014

Matrix metalloproteinases and E-cadherin immunoreactivity in different basal cell carcinoma histological types

Lucija Vanjaka-Rogošić; Neira Puizina-Ivić; Lina Mirić; Veljko Rogošić; Ivana Kuzmić-Prusac; Mirna Saraga Babić; Dubravka Vuković; Snježana Mardešić

The immunohistochemical staining of matrix metalloproteinases (MMPs) and E-cadherin in tumor epithelial and stromal cells was analyzed in a group of solid, superficial spreading and cystic tumors and in a group of morpheaform and recurrent basal cell carcinomas (BCC) in order to determine whether any of these factors possibly contribute to tumor therapy resistance. Tumor tissues of 64 patients were obtained by complete excisional or curettage biopsy of BCC and these were immunohistochemically stained for MMP-1, MMP-2, MMP-9, MMP-13 and E-cadherin. In the morpheaform and recurrent BCC, MMP-9 expression significantly increased in the stroma, while E-cadherin expression was negative in epithelial cells. Odds ratio for development of morpheaform and recurrent BCC was 6.2 for positive MMP-1 immunostaining in epithelial tumor cells, 5.8 for positive MMP-9 immunostaining in tumor stroma, 3.2 for positive MMP-13 immunostaining in tumor stroma, and 4.5 for negative E-cadherin in epithelial tumor cells. Our results suggest that MMP-1 immunostaining in tumor cells, MMP-9 expression in stromal cells, and absence of E-cadherin expression are associated with morpheaform and recurrent BCC.


Acta Clinica Croatica | 2017

Structure-Function Relationship of Changes in Visual Field Indices with Quadrant and Average Retinal Nerve Fiber Layer Thickness in the Eyes with Exfoliation

Katia Novak Lauš; Željka Tomić; Marija Šimić Prskalo; Renata Iveković; Valentina Lacmanović Lončar; Ivanka Petric Vicković; Veljko Rogošić; Teo Tomić; Zrinko Prskalo

The progressive nature of glaucoma suggests it should be possible to detect structural changes such as retinal nerve fiber layer (RNFL) thickness loss before the condition becomes clinically apparent with visual field (VF) impairment. Therefore, the aim was to analyze RNFL thickness and VF changes in study groups with unilateral exfoliation syndrome (XFS), bilateral XFS and bilateral exfoliative glaucoma (XFG), and compare it with controls. The study included 114 subjects (228 eyes) divided into 4 groups according to the presence of exfoliation: 30 subjects with unilateral XFS (30 with clinically visible XFS and 30 fellow eyes), 24 subjects (48 eyes) with bilateral XFS, 28 (56 eyes) subjects with bilateral XFG, and control group (32 subjects). All subjects underwent VF and RNFL measurements after ophthalmologic examination. Both eyes of unilateral XFS (clinically -visible and fellow eye) showed positive correlation between Mean Defect (MD) and square root of Loss of Variance (sLV) and between MD and inferior quadrant RNFL thickness. In bilateral XFS and XFG, there was negative correlation between MD and inferior quadrant RNFL thickness. Inferior, superior and nasal quadrant RNFL thickness was lower in XFG group than in other groups. In bilateral XFS group, the inferior quadrant RNFL thickness was lower as compared with unilateral XFS group (in both eyes). The mean RNFL thickness negatively correlated with MD in bilateral XFS and XFG groups. In conclusion, structural changes before VF impairment have an important role in early detection of glaucoma in subjects at risk.


Graefes Archive for Clinical and Experimental Ophthalmology | 2005

Pseudoexfoliation syndrome and asymptomatic myocardial dysfunction

Lovro Bojić; Ratko Ermacora; Polić S; Milan Ivanišević; Zdravko Mandić; Veljko Rogošić; Mladen Lešin


Collegium Antropologicum | 2004

The Incidence of Optic Neuritis in Split-Dalmatia County, Croatia

Lovro Bojić; Milan Ivanišević; Alen Sinicic; Mladen Lešin; Veljko Rogošić; Zdravko Mandić; Branimir Cerovski


Collegium Antropologicum | 2009

Afect of botulinum toxin-A injection on intraocular pressure and proptosis in thyroid associated orbitopathy

Mladen Lešin; Lovro Bojić; Rinaldo Romac; Joško Lešin; Milan Ivanišević; Davor Galetović; Veljko Rogošić


Collegium Antropologicum | 2005

Treatment of Ocular Motility Disturbances in Graves' Disease with Botulinum Toxin A

Neda Stiglmayer; Mladen Lešin; Jelena Juri; Milan Ivanišević; Lovro Boić; Veljko Rogošić


Arhiv Za Higijenu Rada I Toksikologiju | 2003

Frequency of Congenital Dyschromatopsias in Male Population of the Split-Dalmatian County in Croatia

Veljko Rogošić; Lovro Bojić; Ksenija Karaman; Venera Lakoš-Krželj; Damir Mendeš; Milan Ivanišević


Acta medica Croatica : c̆asopis Hravatske akademije medicinskih znanosti | 2013

PROGNOSTIC VALUE OF OPHTHALMIC ARTERY COLOR DOPPLER SONOGRAPHY FOR PROGRESSION TO GLAUCOMA IN VITILIGO PATIENTS

Darko Duplančić; Veljko Rogošić; Neira Puizina-Ivić; Lucija Vanjaka Rogošić; Boris Lukšić; Vedran Kovacic; Kolja Poljak; Katia Novak-Lauš

Collaboration


Dive into the Veljko Rogošić's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge